Related Articles
Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer
A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer
Sequential administration of XELOX and XELIRI is effective, feasible and well tolerated by patients with metastatic colorectal cancer
First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer